Guo and colleagues reported that the expression of inwardly rectifying potassium channel Kir2.1 (KCNJ2) was regulated by miR-7-5p that modulated multiple drug resistance in SCLC [28]. Here, KCNJ2 is linked to small cell lung carcinoma.